Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Apr 16, 2015; 7(4): 403-410
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.403
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.403
Table 4 Comparison between patients presenting with occult/overt obscure gastrointestinal bleeding
| Variable | Occult OGIB | Overt OGIB | P |
| Age (years old) | 66 | 68 | 0.448 |
| Sex (M/F) | 24/54 | 16/19 | 0.141 |
| [Hb] (median) | 8.9 | 7.9 | 0.015 |
| Anticoagulant use (n) | 8 | 3 | 1.000 |
| Time from OGIB to WCE (d; median) | 31 | 29 | 0.653 |
| Follow-up period (mo; median) | 48 | 42 | 0.450 |
| Rebleeding cumulative events (at 12 mo) (n) | 9% (7) | 21% (7) | 0.133 |
| Rebleeding cumulative events (at 36 mo) (n) | 20% (13) | 39% (11) | |
| Rebleeding cumulative events (at 60 mo) (n) | 29% (16) | 39% (11) | |
| Rebleeding cumulative events (at 84 mo) (n) | 34% (17) | 49% (12) | |
| Rebleeding cumulative events (total) (n) | 17 | 12 | |
| Time to rebleeding event (mo; IQR) | 22 (6-33) | 8.5 (0.5-27) | 0.257 |
- Citation: Magalhães-Costa P, Bispo M, Santos S, Couto G, Matos L, Chagas C. Re-bleeding events in patients with obscure gastrointestinal bleeding after negative capsule endoscopy. World J Gastrointest Endosc 2015; 7(4): 403-410
- URL: https://www.wjgnet.com/1948-5190/full/v7/i4/403.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i4.403